PRQR
ProQR Therapeutics BV
1.60$
-3.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +923.3% | -81.6% | -21.2% | -561.9% | – | – | +63.2% | +241.7% | +44.3% | -91.6% | -100.0% | – | – | -100.0% | – | – | -100.0% | – | – | +77.1% | -79.4% | +415.1% | -16.4% | -13.7% | +36.4% | -42.4% | +78.3% | +10.2% | +139.7% | +35.5% | +41.7% | -39.0% | +12.1% | +4.9% | -15.5% | -23.6% | +59.3% | -55.5% | +330.9% | – | |
| – | -26.6% | +25.4% | +14.5% | -0.3% | +12.5% | +10.9% | +20,474,585.1% | +140,661.8% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2.8% | – | – | – | – | – | – | +4.9% | +1.9% | – | |
| – | – | -88.0% | -343.6% | – | – | – | +63.2% | +241.7% | +44.3% | -76.4% | +43.4% | -31.2% | -10,087.6% | – | – | – | – | – | – | +77.1% | -79.4% | +415.1% | -16.4% | -13.7% | +36.4% | -42.4% | +78.3% | +10.2% | +139.7% | +35.5% | +41.7% | -39.0% | +12.1% | +4.9% | -15.5% | -23.6% | +36.2% | -65.7% | +501.4% | – | |
| – | -2.6% | -0.9% | -6.0% | -4.3% | +15.5% | -7.9% | -22.1% | +5.1% | +51.5% | +25.4% | -20.4% | +16.3% | +25.8% | -7.9% | -33.0% | -3.3% | +1.4% | +5.8% | +9.3% | +14.3% | +12.0% | +7.3% | -14.3% | +34.1% | -30.3% | -43.4% | -2.5% | -7.8% | +42.0% | +20.0% | -24.1% | +33.6% | +12.7% | +16.1% | -7.4% | -2.9% | -11.3% | +22.3% | +7.1% | – | |
| – | +12.9% | +1.9% | +25.5% | -4.8% | +5.0% | -7.6% | -0.9% | -2.6% | +79.9% | -31.2% | -9.9% | +0.9% | +34.9% | +0.0% | -12.0% | -18.5% | +25.0% | -4.9% | +23.5% | +11.4% | +15.8% | -7.7% | +10.3% | -1.0% | -44.5% | +35.5% | +3.0% | -20.0% | +43.3% | -27.3% | -12.7% | +9.0% | +19.2% | -17.4% | +48.9% | -35.2% | +24.8% | -1.0% | +27.6% | – | |
| – | +0.4% | -2.9% | +2.3% | -3.0% | +12.6% | -7.8% | -24.9% | +14.1% | +59.8% | +6.9% | -18.2% | +8.5% | +29.6% | -5.4% | -79.6% | +223.4% | +7.4% | +3.7% | +14.5% | +13.4% | +13.1% | +2.8% | -7.7% | +22.8% | -34.0% | -26.2% | -0.3% | -12.9% | +9.0% | +31.1% | -20.9% | +26.8% | +14.6% | +6.6% | +4.8% | -11.6% | -8.4% | +17.1% | +12.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.5% | +100.4% | +120.5% | -26.7% | -41.7% | +69.8% | -90.0% | -14.1% | +97.3% | +919.4% | -64.3% | +283.0% | -18.4% | – | – | +167.3% | -99.1% | +1,731.3% | +741.0% | – | – | +4,226.3% | -85.5% | +421.0% | +98.1% | -55.7% | -99.8% | +921.1% | +2,520.8% | -99.0% | -9.7% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -666.1% | – | +59,100.0% | -100.8% | – | – | – | -3,400.0% | – | – | – | -181.3% | – | -133.8% | – | +581.8% | -49.3% | -81.6% | +657.1% | -34.0% | -37.1% | -68.2% | +185.7% | +245.0% | -1,198.6% | – | – | -2.4% | -87.8% | -40.0% | -6,766.7% | – | – | – | – | – | – | +0.9% | +2,441.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.